← All trials
NCT05007080
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 27, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Oct 31, 2023
- First posted
- Aug 16, 2021
- Last posted
- Dec 2, 2021
- Enrollment
- 3300
- Arms / groups
- 12 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Janssen Pharmaceutica NVLead sponsor
- Janssen Pharmaceutica NVStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.